Martine van Vugt
Director/Miembro de la Junta en SCANDION ONCOLOGY A/S .
Origen de la red de primer grado Martine van Vugt.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
54
| Public Company | Pharmaceuticals: Major | 54 |
| Public Company | Pharmaceuticals: Major | 17 | |
| Public Company | Biotechnology | 5 | |
Immagene BV
 Immagene BV Pharmaceuticals: MajorHealth Technology Immagene BV is a private biotech company based in the Netherlands that is dedicated to developing next-generation precision immuno-oncology treatments. Immagene is committed to transforming cancer treatment and has a focus on precision medicine. The Dutch company was founded on world-leading research from the Netherlands Cancer Institute and drug R & D expertise from industry veterans. The company was founded by Maarten Ligtenberg, Christian Blank, and Daniel Peeper, with Maarten Ligtenberg serving as the CEO since incorporation.
4
| Holding Company | Pharmaceuticals: Major | 4 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Martine van Vugt a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
| University of Copenhagen | College/University | Doctorate Degree Doctorate Degree Graduate Degree Graduate Degree Corporate Officer/Principal Graduate Degree Graduate Degree Graduate Degree Doctorate Degree Corporate Officer/Principal Graduate Degree Doctorate Degree | |
| Copenhagen Business School | College/University | Undergraduate Degree Graduate Degree Graduate Degree Masters Business Admin Graduate Degree Graduate Degree | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Human Resources Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Medarex, Inc.
 Medarex, Inc. Miscellaneous Commercial ServicesCommercial Services Medarex, Inc. provides commercial physical and biological research services. The company's UltiMAb, a human antibody development system creates and develops antibodies products for cancer, rheumatoid arthritis, inflammatory, autoimmune, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey. | Miscellaneous Commercial Services | Chairman Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Genmab, Inc.
 Genmab, Inc. Miscellaneous Commercial ServicesCommercial Services Genmab, Inc. creates and develops human antibodies for the treatment of life-threatening and debilitating diseases. It also offers products for cancer and autoimmune disorders. The company is headquartered in Princeton, NJ. | Miscellaneous Commercial Services | Chief Executive Officer Director/Board Member Director/Board Member Director/Board Member | |
Azanta A/S
 Azanta A/S Pharmaceuticals: MajorHealth Technology Azanta A/S develops pharmaceutical drugs for medical treatments in women´s health, oncology and addiction medicine. Its products include Angusta, which helps in cervical ripening and induction of labor. The firm also develops drugs for the treatment of head and neck cancer patients undergoing with radiotherapy. The company was founded by Claus Juan Møller-San Pedro and Jan Andersen in 1994 and is headquartered in Valby, Denmark. | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO Director/Board Member Chief Executive Officer | |
| H. LUNDBECK A/S | Pharmaceuticals: Major | Chairman Chief Tech/Sci/R&D Officer Director of Finance/CFO Corporate Officer/Principal | |
| Y-MABS THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO Chief Tech/Sci/R&D Officer Chief Operating Officer | |
| University of Utrecht | College/University | Corporate Officer/Principal Doctorate Degree Doctorate Degree Corporate Officer/Principal | |
| NOVO NORDISK A/S | Pharmaceuticals: Major | Public Communications Contact Corporate Officer/Principal Corporate Officer/Principal | |
Roche Innovation Center Copenhagen A/S
 Roche Innovation Center Copenhagen A/S Pharmaceuticals: MajorHealth Technology Roche Innovation Center Copenhagen A/S discovers and develops drugs for the treatment of oncology, metabolic diseases, and infectious diseases. The firm manufactures a pipeline of drug candidates that act selectively on disease-related ribonucleic acid to provide patients with novel treatments for both rare and common diseases. It produces pre-clinical and clinical assets for the treatment of a range of diseases including oncology, metabolic diseases, and infectious diseases. The company was founded by Matts Lundwall and Mikael Ørum on January 1, 1998 and is headquartered in Horsholm, Denmark. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal Chief Executive Officer | |
| Rutgers State University of New Jersey | College/University | Masters Business Admin Graduate Degree Undergraduate Degree | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| University of Leiden | College/University | Graduate Degree Doctorate Degree Corporate Officer/Principal | |
| University of Aarhus | College/University | Graduate Degree Graduate Degree Doctorate Degree | |
| Princeton University | College/University | Corporate Officer/Principal Corporate Officer/Principal Graduate Degree | |
| Universität zu Köln | College/University | Graduate Degree Doctorate Degree | |
BioNJ, Inc.
 BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services BioNJ, Inc. is based in Trenton, NJ. BioNJ, Inc. is a life sciences trade association with nearly 400 member companies. The company supports the discovery, development, and commercialization of therapies and cures that save and improve lives. BioNJ drives capital formation, fosters entrepreneurship, advocates for medical innovation, provides access to talent and education, and offers critical commercial resources. The company also serves as a clearinghouse for funding information and opportunities. The company was founded in 1994 by James J. Marino, Jayne C. Gershkowitz, Abraham Abuchowski. The CEO is Debbie Hart. | Miscellaneous Commercial Services | Corporate Secretary Corporate Officer/Principal | |
| SANOFI | Biotechnology | Public Communications Contact General Counsel | |
| Radboud University Nijmegen | College/University | Doctorate Degree Undergraduate Degree | |
| WNTRESEARCH AB | Pharmaceuticals: Other | Chief Executive Officer General Counsel | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
KLIFO A/S
 KLIFO A/S Miscellaneous Commercial ServicesCommercial Services KLIFO A/S provides clinical research services. Its services include development plans, protocols, project management, monitoring, data management and statistics, reporting, regulatory affairs, importing, packaging, labeling, and distribution of clinical trials. The company provides services to the pharmaceutical and medical devices industries. KLIFO was founded by Dr. Allan Rosetzsky in 1994 and is headquartered in Copenhagen, Denmark. | Miscellaneous Commercial Services | Chief Executive Officer Corporate Officer/Principal | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Corporate Officer/Principal Undergraduate Degree | |
| Danmarks Farmaceutiske Universitet | College/University | Graduate Degree Graduate Degree | |
| VELOXIS PHARMACEUTICALS A/S | Pharmaceuticals: Major | Director of Finance/CFO Director of Finance/CFO | |
| The Trustees of Columbia University in The City of New York | College/University | Masters Business Admin Corporate Officer/Principal | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal | |
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Director of Finance/CFO | |
| STALLERGENES | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| CARDINAL HEALTH, INC. | Medical Distributors | Corporate Officer/Principal Corporate Officer/Principal | |
NOXXON Pharma AG
 NOXXON Pharma AG BiotechnologyHealth Technology NOXXON Pharma AG operates a clinical stage biotechnology company. Its core focus is on cancer treatment. The firm offers effectiveness of cancer treatments including immuno-oncology approaches such as immune checkpoint inhibition and current standards of care such as chemotherapy and radiotherapy. The company was founded in 1997 by Sven Klussmann, Jens-Peter Fürste and Thomas Klein and is headquartered in Berlin, Germany. | Biotechnology | Director/Board Member Director/Board Member | |
| Jatana Aps | Director/Board Member | ||
| Npc Moirai ApS | Director/Board Member | ||
Aimvion A/S
 Aimvion A/S Pharmaceuticals: MajorHealth Technology Aimvion A/S provides services for autoimmune diseases and biotechnology. The private company is based in Copenhagen, Denmark. | Pharmaceuticals: Major | Chairman | |
| ROS-Therapeutics ApS | Chief Executive Officer | ||
| Medical Technology Innovation Consortium | Chairman | ||
| Sparring Bioconsult BV | Chief Executive Officer | ||
| Yale University | College/University | Undergraduate Degree | |
| University of Amsterdam | College/University | Doctorate Degree | |
| CURASIGHT A/S | Medical Specialties | Chief Operating Officer | |
The Scripps Research Institute
 The Scripps Research Institute Other Consumer ServicesConsumer Services The Scripps Research Institute is a private, non-profit research organizations that performs basic biomedical research in molecular & cellular biology, chemistry, immunology and neuroscience. They receive the majority of its funding from federal agencies such as the National Institutes of Health. The organization also partners with pharmaceutical companies and is affiliated with the Scripps hospital group. The organization was founded in 1955 and is headquartered in La Jolla, California. | College/University | Corporate Officer/Principal | |
| Scandinavian International Management Institute | College/University | Masters Business Admin | |
| LAVA THERAPEUTICS N.V. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal |
Estadísticas
Internacional
| Dinamarca | 21 |
| Estados Unidos | 18 |
| Países Bajos | 7 |
| Alemania | 3 |
| Francia | 3 |
Sectorial
| Health Technology | 23 |
| Consumer Services | 17 |
| Commercial Services | 6 |
| Distribution Services | 2 |
| Technology Services | 2 |
Operativa
| Director/Board Member | 273 |
| Corporate Officer/Principal | 123 |
| Chairman | 92 |
| Independent Dir/Board Member | 64 |
| Chief Executive Officer | 49 |
Las relaciones más conectadas
- Bolsa de valores
- Insiders
- Martine van Vugt
- Conexiones Empresas
